SCHEMBL10552154

SCHEMBL10552154

CC1CC(=O)NN=C1c1ccc(-n2cnc3ccccc32)nc1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PDE3A Q14432 13/20 0.48
▸ PDE3B Q13370 11/20 0.48
▸ PDE2A O00408 2/20 0.48
▸ PDE1A P54750 1/20 0.48
▸ PDE1B Q01064 1/20 0.48
▸ PDE1C Q14123 1/20 0.48
▸ PDE4B Q07343 6/20 0.45
▸ PDE4A P27815 3/20 0.45
▸ PDE4C Q08493 3/20 0.45
▸ PDE4D Q08499 3/20 0.45
▸ MAPT P10636 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ GPR119 Q8TDV5 4/20 0.44
▸ PDE5A O76074 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10688158 0.87 PDE3A (0.47) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10629606 0.86 PDE3B (0.62) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10548993 0.78 PDE3B (0.54) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10553519 0.78 PDE3B (0.54) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10554322 0.78 PDE3B (0.76) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10552102 0.76 PDE3B (0.38) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10469492 0.75 PDE3B (0.71) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10553072 0.75 PDE3B (0.50) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10547986 0.75 PDE3B (0.50) PDE3APDE3BPDE2APDE1APDE1B
SCHEMBL10549361 0.73 PDE3B (0.50) PDE3APDE3BPDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4847251-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-07-11 — — US claimed
EP-0255704-A2 Pyridazinone derivatives, process for their preparation and their use as medicines Roche Diagnostics GmbH (DE) 1988-02-10 — — EP disclosed
Send feedback